Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Bedford Pharmacy is recalling four vials of P-P (COBAL) 30-2 /mL Injection because of a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling P-P-P (COBAL) 30-4-40/mL Injection vials because there is a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling Methylcobalamin 1 mg/mL Injection because there is a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling 4 vials of P-P-P (COBAL) 30-1-20/mL Injection due to a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling Hydroxocobalamin 20 mg/mL Injection due to a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling Testosterone Cypionate injections due to a lack of assurance of sterility. The affected products were distributed in New Hampshire and Massachusetts.
Nephron Pharmaceuticals is recalling Ipratropium Bromide and Albuterol Sulfate inhalation solution due to a lack of assurance of sterility.
Apotex Inc. is recalling specific lots of Bromfenac Ophthalmic Solution 0.09% because preservative testing failed, raising concerns about sterility.
Bedford Pharmacy is recalling P-P (COBAL) 30-0.5/mL injections because there is a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling two bottles of Acetylcysteine 10% Ophthalmic Solution because there is a lack of assurance of sterility.
Bedford Pharmacy is recalling P-P-P (COBAL) 30-1-5/mL Injection vials because the agency could not ensure the product was sterile. The recall affects vials distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling Testosterone Cypionate (Complete Formula) 200 mg/mL injections due to a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Bedford Pharmacy is recalling Methylcobalamin (Bacteriostatic) 1 mg/mL Injection due to a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Midway Importing, Inc. is recalling Sedalmex pain reliever tablets due to potential cross-contamination with cephalosporin. Consumers should stop using the product and return it to the point of purchase.
Bedford Pharmacy is recalling P-P-P (COBAL) 30-2-30/mL injections because of a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
Ohm Laboratories is recalling Equaline loratadine tablets because they failed potency testing. Consumers should stop using the product and return it to the pharmacy.
Ohm Laboratories is recalling specific lots of loratadine tablets because they failed potency testing. Consumers should stop using the affected medication.
The Mentholatum Company is recalling WellPatch Capsaicin Pain Relief Patches because the word 'not' was missing from safety instructions, potentially leading to improper use.
Ohm Laboratories is recalling Good Neighbor Pharmacy Loratadine Orally Disintegrating Tablets because they failed potency testing.
Ohm Laboratories is recalling specific batches of loratadine orally disintegrating tablets because they failed potency testing. Consumers should stop using the affected products.
Ohm Laboratories is recalling 311 boxes of Allergy Relief (Loratadine) tablets due to an out-of-specification assay result.
Ohm Laboratories is recalling Meijer Loratadine Orally Disintegrating Tablets due to an out-of-specification assay result.
Ohm Laboratories is recalling QC Quality Choice Loratadine Orally Disintegrating Tablets due to an out-of-specification assay result.
Boehringer Ingelheim Roxane Inc. is recalling 5,160 bottles of Furosemide Tablets USP because the wrong active ingredient was used during manufacturing.
Ohm Laboratories is recalling specific batches of Leader Loratadine Orally Disintegrating Tablets because they failed potency testing. Consumers should stop using the affected products.